Theres a new version of agonists thats coming out that are non peptide
Insulin Effective 2023 Beginning in 2023, for Medicare Part D beneficiaries who need insulin, monthly out-of-pocket costs will be capped at $35, and starting in 2026, the cap would be $35 or 25% of the negotiated price if that is lower
Learn More Lymphatic Drainage Therapy Lymphatic drainage supports the detoxification and circulation pathways that peptide therapy relies on enhancing recovery, reducing inflammation, and clearing metabolic waste
Elevated plasma glucose levels and dyslipidemia have been associated with proinflammatory cytokine production, suggesting a mechanistic link between type 2 diabetes, inflammation, and atherosclerotic cardiovascular (CV) disease [1, 2], and this inflammatory state may contribute to the development and progression of type 2 diabetes [2]